The New York Times this week had a column on "a troubling new report from the Agency for Healthcare Research and Quality, which analyzed hundreds of studies in an effort to advise men about the best treatments for prostate cancer. The report compared the effectiveness and risks of eight prostate cancer treatments, ranging from prostate removal to radioactive implants to no treatment at all. None of the studies provided definitive answers. Surprisingly, no single treatment emerged as superior to doing nothing at all."
An AHRQ news release said, “Considerable overdetection and overtreatment may exist."
Posted by schwitz at February 10, 2008 10:51 AM | TrackBack